Citation Impact
Citing Papers
Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation
2001 StandoutNobel
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
1989
Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.
1989
Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.
1982
Assessment of severity in colitis: a preliminary study.
1975
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.
1997
Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.
1985
Duodenal inhibition of gastric secretion by osmotic agents in normal subjects and patients with duodenal ulcer
1969
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.
1980
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2005
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis
1998
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Global Cancer Statistics, 2002
2005 Standout
Ulcerative Colitis
2011 Standout
Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis
1990
Drug Insight: aminosalicylates for the treatment of IBD
2007
Changes in Extent of Ulcerative Colitis A Study on the Course and Prognostic Factors
1996
Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease
1996
Evaluation and stages of surgical innovations
2009 Standout
Cushing's syndrome
2015 Standout
Drug-Induced Acute Pancreatitis
1989
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Race, Gender, and Partnership in the Patient-Physician Relationship
1999 Standout
Drug-Induced Hepatotoxicity
2003 Standout
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Ulcerative Colitis and Colorectal Cancer
1990 Standout
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2002
Celiac Disease
2007 Standout
Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis
1992
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
1999 Standout
Course of ulcerative colitis: Analysis of changes in disease activity over years
1994
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Inflammatory Bowel Disease
1991 Standout
Characterization of Liver T–Cell Receptor γδ+ T Cells Obtained From Individuals Chronically Infected With Hepatitis C Virus (Hcv): Evidence for These T Cells Playing A Role in the Liver Pathology Associated With Hcv Infections
2001 StandoutNobel
Ulcerative colitis
2012 Standout
Helicobacter pylori: the African enigma.
1992
Inflammatory Bowel Disease
2002 Standout
Effects of Estrogen Receptor Expression and Histopathology on Annual Hazard Rates of Death from Breast Cancer
2006
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
1987 Standout
Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis
1995
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians
2007 Standout
Ulcerative colitis
2016 Standout
The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro‐drugs used in the management of ulcerative colitis
2002
In vitro induction of chromosome damage by sulphasalazine in human lymphocytes
1989
Innovation in Surgery
2006
Acute Pancreatitis
1994 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis
1988
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
1998
Non-medical influences on medical decision-making
1996
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2012
Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers
1999
Drug Therapies for Ulcerative Proctitis
2014
Colectomy rate in acute severe ulcerative colitis in the infliximab era
2008
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Oral Mesalamine (Asacol) for Mildly to Moderately Active Ulcerative Colitis
1991
Biology and biochemistry of papillomaviruses
1984
Radioimmunoassay in Gastroenterology
1972 StandoutNobel
Epidemiological aspects of Crohn's disease: a review of the literature.
1984
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2006
Kinetics of 5‐aminosalicylic acid after jejunal instillation in man.
1983
Immunochemical Measurement of Elevated Levels of Gastrin in the Serum of Patients with Pancreatic Tumors of the Zollinger-Ellison Variety
1968
Ectopic ACTH Production in Carcinoma of the Lung
1974 StandoutNobel
Assessing Quality and Efficiency of Discharge Summaries
2005
ANTIBODIES TO SYNTHETIC HUMAN GASTRIN I
1967
Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis
2005
Intestinal Phase of Gastric Acid Secretion: Augmentation of Maximal Response of Heidenhain Pouch to Gastrin and Histamine
1975
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.
1988
TRYPTOPHAN IN THE TREATMENT OF DEPRESSION
1967
Clinical and Laboratory Studies of Ectopic Humoral Syndromes
1969
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
1977 Standout
Effect of Bile Salts on Antral Gastrin Release
1971
Heberden Oration, 1963
1964
Serum Gastrin Levels in Patients with Peptic Ulcer Disease
1970
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2016
Pharmacologic and Endocrine Aspects of Carcinoid Syndrome
1967
The Reaction of Glucagon with Its Receptor: Evidence for Discrete Regions of Activity and Binding in the Glucagon Molecule
1971 StandoutNobel
PROSTACYCLIN CAN REPLACE HEPARIN IN HÆMODIALYSIS IN DOGS
1978 StandoutNobel
The Isolation and Characterization of Porcine Gastrin
1965
5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in Humans
1982
Somatostatin Inhibition of Insulin and Gastrin Hypersecretion in Pancreatic Islet-Cell Carcinoma
1975 StandoutNobel
Intestinal Hormones as Inhibitors of Gastric Secretion
1971
Gastric hypersecretion produced by massive small bowel resection in dogs
1964
The Effect of Atropine on Plasma Gastrin Response to Feeding
1971 StandoutNobel
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
1987 Standout
SEROTONIN IMMUNOREACTIVITY IN CARCINOID TUMOURS DEMONSTRATED BY A MONOCLONAL ANTIBODY
1982 StandoutNobel
HEREDITARY HÆMORRHAGIC TELANGIECTASIA AND ORAL CONTRACEPTIVES
1970 Standout
EFFECTS IN MAN OF HISTAMINE H2-RECEPTOR BLOCKADE BY BURIMAMIDE
1972 StandoutNobel
Assessing illness severity: Does clinical judgment work?
1986
Relation of Massive Bowel Resection to Gastric Secretion
1965
Sulfasalazine-Induced Exacerbation of Ulcerative Colitis
1982
Hypersecretion of Gastrin Associated with the Short Bowel Syndrome
1974 StandoutNobel
Mesalazine (5-aminosalicylic acid) induced chronic hepatitis
1999
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease
2016
Azodisal sodium in the treatment of ulcerative colitis
1986
Discovery of aminoacyl-tRNA synthetase activity through cell-surface display of noncanonical amino acids
2006 StandoutNobel
Alternatives to sulfasalazine: A meta-analysis of 5-ASA in the treatment of ulcerative colitis
1997
NATURE OF THE GASTRIC SECRETAGOGUE IN ZOLLINGER-ELLISON TUMOURS
1967
Size and Charge Distinctions Between Endogenous Human Plasma Gastrin in Peripheral Blood and Heptadecapeptide Gastrins
1970 StandoutNobel
Gastrin in Duodenal Ulcer
1971 StandoutNobel
Direct and metabolism‐dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes.
1991
Importance of vagal innervation in the regulatory effect of acid in the duodenum on gastric secretion of acid
1955
Effect of Growth Hormone Release-Inhibiting Hormone on Gastric Secretion, Mucosal Blood Flow, and Serum Gastrin
1976 StandoutNobel
ŒSTROGEN TREATMENT OF RECURRENT APHTHOUS MOUTH ULCERS
1967
Pancreatic Scanning: A Review
1972 StandoutNobel
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2006
Massive bowel resection and gastric hypersecretion
1967
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer.
1984 StandoutNobel
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Nature of Immunoreactive Gastrin Extracted from Tissues of Gastrointestinal Tract
1971 StandoutNobel
POTENTIATION OF ANTIDEPRESSANT ACTION OF CLOMIPRAMINE BY TRYPTOPHAN
1975 StandoutNobel
An oral preparation to release drugs in the human colon.
1982
ANKYLOSING SPONDYLITIS AND HL-A 27
1973 Standout
Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease
1980
INTENSIVE INTRAVENOUS REGIMEN FOR SEVERE ATTACKS OF ULCERATIVE COLITIS
1974
Duodenal inhibition of gastric secretion by osmotic agents in normal subjects and patients with duodenal ulcer.
1969
The preparation and properties of gastrin
1961
TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS
1981
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
2016
Effect of Perfusion of Intestinal Loops with Acid, Fat, or Dextrose on Gastric Secretion
1965
Radioimmunoassay of gastrin
1970 StandoutNobel
The effects of 5‐hydroxytryptamine on gastric secretion in anaesthetized dogs
1958 StandoutNobel
A family study of ulcerative colitis. With particular reference to ankylosing spondylitis and sacroiliitis.
1973
Islet Cell Tumors: Current Concepts and Management
1973
Bloody diarrhea—a new complication of sulfasalazine
1978
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
1985 StandoutNatureNobel
Pancreatic Islet Cell Carcinoma
1973
Haemostatic Changes during Dialysis Associated with Thrombus Formation on Dialysis Membranes
1972
Sulfasalazine
1983
Serum Gastrin Concentrations in Pernicious Anemia
1970
Contemporary Developments in the Biochemistry of the Gastrointestinal Hormones
1967
Works of W. Sircus being referenced
Betamethasone 17-Valerate and Prednisolone 21-Phosphate Retention Enemata in Proctocolitis: A MULTICENTRE TRIAL
1971
An experience of ulcerative colitis. I. Toxic dilation in 55 cases.
1969
The metabolism of salicylazosulphapyridine in ulcerative colitis
1973
Bio-assay evidence of abnormal secretin-like and gastrin-like activity in tumour and blood in cases of `choleraic diarrhoea'
1970
Ankylosing Spondylitis and Chronic Inflammatory Diseases of the Intestines
1963
MILESTONES IN THE EVOLUTION OF ENDOSCOPY: A SHORT HISTORY*
2003
Malignant lymphoma and extensive viral wart formation in a patient with intestinal lymphangiectasia and lymphocyte depletion
1977
Duodenitis: A Clinical, Endoscopic and Histopathologic Study
1985
Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator Phenotype
1973
SCINTILLOGRAPHY IN THE DIAGNOSIS OF PANCREATIC DISEASE
1968
STUDIES ON THE MECHANISMS IN THE DUODENUM INHIBITING GASTRIC SECRETION
1958
Comparative Evaluation of Water Recovery Test and Fluoroscopic Screening in Positioning a Nasogastric Tube during Gastric Secretory Studies
1972
Evidential value of the hospital record in clinical decision making.
1979
RECURRENT APHTHOUS ULCERATION OF THE MOUTH<subtitle>A Study of the Natural History, Aetiology, and, Treatment</subtitle>
1957
Nature of the inflammatory cell infiltrate in duodenitis.
1983
THE EFFECT OF B1‐PYRIMIDINE ON GASTRIC SECRETION
1953
The rationale of selective surgery in the treatment of duodenal ulcer.
1959
EXTRACTION OF A GASTRIN-LIKE SUBSTANCE FROM A PANCREATIC TUMOUR IN A CASE OF ZOLLINGER-ELLISON SYNDROME
1960
THE INTESTINAL PHASE OF GASTRIC SECRETION
1953
ANTRAL-GASTRIN-CELL HYPERPLASIA IN PEPTIC-ULCER DISEASE
1974
Clinical Features in Patients With the Carcinoid Syndrome
1965
EVIDENCE FOR A GASTRIC SECRETAGOGUE IN THE CIRCULATION AND GASTRIC JUICE OF PATIENTS WITH THE ZOLLINGER-ELLISON SYNDROME
1964
A trial of hypnosis in the management of recurrent mouth ulceration
1964
An Experience of Ulcerative Colitis
1970
Ulcerative colitis. A clinical study of 399 patients.
1971
The Management of Recurrent Aphthous Stomatitis
1959
The Role of the Colon in the Metabolism of Salicylazosulphapyridine
1974
The British Society Of Gastroenterology
1955
An Experience of Ulcerative Colitis
1970
An Experience of Ulcerative Colitis
1969